Christophe Claude Parsy
24Patents
6h-index
28Co-inventors
65Inventor score
Filing activity: Aug 20, 2008 → Nov 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8507460B2 | Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections | Chemistry; Metallurgy | 48 | Active |
| US8362068B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | Chemistry; Metallurgy | 44 | Active |
| US9109001B2 | 3′,5′-cyclic phosphoramidate prodrugs for HCV infection | Chemistry; Metallurgy | 44 | Active |
| US9296778B2 | 3′,5′-cyclic phosphate prodrugs for HCV infection | Chemistry; Metallurgy | 18 | Active |
| US9309275B2 | 3′-deoxy nucleosides for the treatment of HCV | Chemistry; Metallurgy | 17 | Active |
| US8003659B2 | Macrocyclic serine protease inhibitors | Human Necessities | 8 | Active |
| US8377962B2 | Macrocyclic serine protease inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8362018B2 | Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections | Human Necessities | 5 | Active |
| US8309737B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 4 | Active |
| US10030044B2 | Nucleotides for the treatment of liver cancer | Human Necessities | 4 | Active |
| US8481748B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 2 | Active |
| US10815264B2 | Nucleotides for the treatment of cancer | Human Necessities | 1 | Active |
| US8410313B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 1 | Active |
| US8765966B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 1 | Active |
| US9115095B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 0 | Active |
| US9353100B2 | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections | Chemistry; Metallurgy | 0 | Active |
| US11730748B2 | Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases | Chemistry; Metallurgy | 0 | Active |
| US8993595B2 | Macrocyclic serine protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9187496B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9284307B2 | Macrocyclic serine protease inhibitors | Human Necessities | 0 | Active |
| US11040975B2 | Carbocyclic nucleoside reverse transcriptase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10513534B2 | 2′-chloro nucleoside analogs for HCV infection | Chemistry; Metallurgy | 0 | Active |
| US10231986B2 | Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV | Chemistry; Metallurgy | 0 | Active |
| US10766917B2 | Nucleotides for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.